Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 57
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: NGR010|EUDRACT Number: 2006-005993-39
Study First Received: June 7, 2007
Last Updated: October 26, 2015
Estimated Primary Completion Date: September 2010
Primary Outcome Measures:
• Antitumor activity defined as progression free survival (PFS)|• Tumor Growth Control Rate (TGCR) according to RECIST criteria • Overall survival (OS)|• Experimental Imaging Study (DCE-MRI)|• Pharmacokinetics in patients treated with weekly schedule|•Safety
Sponsors and Collaborators:
MolMed S.p.A.
Website Link: https://ClinicalTrials.gov/show/NCT00484276
